These results, along with a earlier report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 assist the principle of concentrating on ACKR3 as a novel way to modulate the opioid method, which could open new therapeutic avenues for opioid-connected disorders.Researchers believe that blocking this scavenge